Our Mission
KosBio is a pioneering biotechnology startup, born out of a deeply personal and transformative mission: to develop an innovative treatment for Friedreich’s Ataxia (FRDA), a rare and incurable neurodegenerative disease. Our founders, intimately connected to FRDA through their own family experiences, bring a unique level of commitment and dedication to this mission, distinguishing KosBio in the competitive biotech landscape.
By harnessing the power of stem cell modeling, artificial intelligence, and patient-specific organoids, our organization is dedicated to creating cutting-edge therapies that offer hope, improve quality of life, and make a lasting impact on patients and their families who face the challenges of FRDA and other rare diseases."